Resources from the same session
2122 - The role of EGFR inhibitor (EGFRi) in immune cell infiltration and CD8+ T-cell activation in EGFR mutant lung cancer
Presenter: Fenge Li
Session: Poster Discussion session - Basic science
Resources:
Abstract
5436 - The mutational signature of spontaneously developing tumors in MLH1-/- mice – potential consequences for immunotherapeutic approaches
Presenter: Claudia Maletzki
Session: Poster Discussion session - Basic science
Resources:
Abstract
1051 - Synergistic anti-cancer activity of auranofin with anti-PD-L1 therapy in triple-negative breast cancer
Presenter: Prahlad Raninga
Session: Poster Discussion session - Basic science
Resources:
Abstract
3759 - Identification of a Radio-Immune Signature with High Prognostic Value in Surgically Resected NSCLC
Presenter: Giulia Mazzaschi
Session: Poster Discussion session - Basic science
Resources:
Abstract
4275 - Automatic interpretation of cancer genomes creates the largest repository of tumor genetic driver events
Presenter: Francisco Martínez Jiménez
Session: Poster Discussion session - Basic science
Resources:
Abstract
4745 - Functional Cell Profiling (FCP) of _100,000 CTCs from multiple cancer types identifies morphologically distinguishable CTC subtypes within and between cancer types
Presenter: Adam Jendrisak
Session: Poster Discussion session - Basic science
Resources:
Abstract
4493 - Aurora-B mediated Snail phosphorylation is essential for mitotic spindle checkpoint and for preventing chromosomal instability in breast cancer
Presenter: Bo Xu
Session: Poster Discussion session - Basic science
Resources:
Abstract
816 - Aspartate-_-hydroxylase drives hepatocelluar carcinoma progression to metastasis fueling glutamine via HIF1_-mediated mitophagy
Presenter: Ran Xue
Session: Poster Discussion session - Basic science
Resources:
Abstract
2774 - HORAS5 promotes cabazitaxel resistance in castration resistant prostate cancer via a BCL2A1-dependent survival mechanism
Presenter: Perla Pucci
Session: Poster Discussion session - Basic science
Resources:
Abstract
4166 - Comprehensive genomic profiling (CGP) of carcinoma of unknown primary origin (CUP): Retrospective molecular classification of potentially eligible patients (pts) for targeted or immunotherapy treatment (tx) using the prospective CUPISCO trial’s criteria
Presenter: Jeffrey Ross
Session: Poster Discussion session - Basic science
Resources:
Abstract